Nrf2-mediated oxidative stress response is altered during acquired resistance to the proteasome inhibitor, oprozomib, in multiple myeloma Meeting Abstract


Authors: Gaikwad, S. M.; Zingone, A.; Michalowski, A.; Najera, S.; Quintanilla-Artega, A.; Gorjifard, S.; Simmons, J.; Watson, N.; Landgren, O.; Huang, J.; Mock, B.
Abstract Title: Nrf2-mediated oxidative stress response is altered during acquired resistance to the proteasome inhibitor, oprozomib, in multiple myeloma
Meeting Title: 109th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 78
Issue: 13 Suppl.
Meeting Dates: 2018 Apr 14-18
Meeting Location: Chicago, IL
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2018-07-01
Language: English
ACCESSION: WOS:000468819505264
DOI: 10.1158/1538-7445.Am2018-5850
PROVIDER: wos
Notes: Meeting Abstract: 5850 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Carl Ola Landgren
    336 Landgren